Summary of Significant Accounting Policies (Details Textual) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
|
| Restricted Cash and Cash Equivalents, Noncurrent | $ 45,000 | $ 20,000 | |||
| Money Market Funds Fair Value | 1,500,882 | 7,200,450 | |||
| Contingent Consideration Funds Fair Value | 1,210,000 | 0 | |||
| Deferred Tax Liabilities, Net, Noncurrent | 1,525,896 | $ 0 | |||
| Jade Therapeutics, Inc [Member] | |||||
| Goodwill | 1,525,896 | ||||
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles | 3,912,314 | ||||
| Restatement Adjustment [Member] | |||||
| Deferred Tax Liabilities, Net, Noncurrent | $ 1,526,000 | $ 1,526,000 | $ 1,526,000 | ||
| Goodwill | $ 1,526,000 | $ 1,526,000 | $ 1,526,000 | ||
| Department Of Defence And National Science Foundation [Member] | |||||
| Revenue from Grants | $ 445,000 |
| X | ||||||||||
- Definition These lines are represents the fair value of fund for contingent consideration. No definition available.
|
| X | ||||||||||
- Definition These lines are represents the fair value of fund for money market. No definition available.
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|